Nanogene editing drug delivery systems in the treatment of liver fibrosis
Frontiers in Medicine · 25.09.2024 · 11
DOI: 10.3389/fmed.2024.1418786 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Medicine, online erschienen am 25.09.2024. Verfasst von Qun Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Qinglan Project of Jiangsu Province of China.
Abstract (Originalsprache)
Liver fibrosis is a group of diseases that seriously affect the health of the world’s population. Despite significant progress in understanding the mechanisms of liver fibrogenesis, the technologies and drugs used to treat liver fibrosis have limited efficacy. As a revolutionary genetic tool, gene editing technology brings new hope for treating liver fibrosis. Combining nano-delivery systems with gene editing tools to achieve precise delivery and efficient expression of gene editing tools that can be used to treat liver fibrosis has become a rapidly developing field. This review provides a comprehensive overview of the principles and methods of gene editing technology and commonly used gene editing targets for liver fibrosis. We also discuss recent advances in common gene editing delivery vehicles and nano-delivery formulations in liver fibrosis research. Although gene editing technology has potential advantages in liver fibrosis, it still faces some challenges regarding delivery efficiency, specificity, and safety. Future studies need to address these issues further to explore the potential and application of liver fibrosis technologies in treating liver fibrosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou, China.
- Department of International Medicine, The Second Hospital of Dalian Medical University, Dalian, China.
- Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.
Förderung
- National Natural Science Foundation of China
- Qinglan Project of Jiangsu Province of China
Zitieren
APA
Wang, Q., Jia, S., Wang, Z., Chen, H., Jiang, X., Li, Y., & Ji, P. (2024). Nanogene editing drug delivery systems in the treatment of liver fibrosis. Frontiers in Medicine, 11. https://doi.org/10.3389/fmed.2024.1418786
Vancouver
Wang Q, Jia S, Wang Z, Chen H, Jiang X, Li Y, et al. Nanogene editing drug delivery systems in the treatment of liver fibrosis. Frontiers in Medicine. 2024;11. doi:10.3389/fmed.2024.1418786
BibTeX
@article{Wang2024,
author = {Wang, Qun and Jia, Siyu and Wang, Zihan and Chen, Hui and Jiang, Xinyi and Li, Yan and Ji, Peng},
title = {Nanogene editing drug delivery systems in the treatment of liver fibrosis},
journal = {Frontiers in Medicine},
year = {2024},
volume = {11},
doi = {10.3389/fmed.2024.1418786}
}
EUVIMED